Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × phosphorylethanolamine × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 2 apatinib 2 spartalizumab 1 phosphorylethanolamine 1 olaparib 1 liposomal doxorubicin 1 ivarmacitinib 1 fludarabine 1 camrelizumab 1 anlotinib 1 Valproic Acid 1 Topotecan 1 Talc 1 Pharmaceutical Services 1 Interleukin-2 1 Injections 1 Hydralazine 1 Cyclophosphamide 1 Cisplatin 1 Cerebral Decortication 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02950103 2019-09-30

Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

Secretaria de Estado da Saúde

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡